Clinical Trial Update: Sertraline for Preventing Post-stroke Depression and Improving Rehabilitation Outcomes [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update on sertraline intended to prevent post-stroke depression and improve rehabilitation outcomes, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Stroke

Drugs mentioned

• Sertraline (Sertraline)

Snippet

Sponsor: University of Pittsburgh | Conditions: Cerebrovascular Accident, Depression | Phase 4 | Status: TERMINATED